Aditxt, Inc. Cash and Restricted Cash
Aditxt, Inc. (ADTX) had Cash and Restricted Cash of $268.85 thousand as of 2026-03-31, per its 10-Q filed 2026-05-20.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-05-20
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $268.85K.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3.20M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $163.04K.
- 2025-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $323.68K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-03-31 | $268.85K 10-Q · filed 2026-05-20 | |
| 2025-12-31 | $3.20M 10-Q · filed 2026-05-20 | |
| 2025-09-30 | $163.04K 10-Q · filed 2025-11-18 | |
| 2025-06-30 | $323.68K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $476.42K 10-Q · filed 2026-05-20 | |
| 2024-12-31 | $833.03K 10-Q · filed 2026-05-20 | |
| 2024-09-30 | $358.60K 10-Q · filed 2025-11-18 | $328.60K 10-Q · filed 2024-11-18 |
| 2024-06-30 | $91.22K 10-Q · filed 2025-08-14 | |
| 2024-03-31 | $88.67K 10-Q · filed 2025-05-15 | |
| 2023-12-31 | $97.10K 10-K · filed 2026-03-31 | |
| 2023-09-30 | $1.65M 10-Q · filed 2024-11-18 | |
| 2023-06-30 | $95.95K 10-Q · filed 2024-08-19 | |
| 2023-03-31 | $302.51K 10-Q · filed 2024-05-20 | |
| 2022-12-31 | $2.77M 10-K · filed 2025-03-31 | |
| 2022-09-30 | $9.24M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $803.97K 10-Q · filed 2023-08-14 | |
| 2022-03-31 | $2.12M 10-Q · filed 2023-05-15 | |
| 2021-12-31 | $7.87M 10-K · filed 2024-04-16 | |
| 2021-09-30 | $5.47M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $8.61M 10-Q · filed 2022-08-15 | |
| 2021-03-31 | $14.05M 10-Q · filed 2022-05-16 | |
| 2020-12-31 | $10.50M 10-K · filed 2023-04-17 | |
| 2019-12-31 | $4.09K 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |